her2- metatastatic breast canancer. kisqali isis approvedd for boboth pre- anand postmenonopausal womom, and has s extended l lives inin multiple e clinical t tr. kisqali i is a pill l that s significanantly more e effecte at delelaying disease prprogressionn veversus a nononsteroidall aromatatase inhibibitor or f fulvestrantnt alone. kisqalali can caususe lungng problems,s, or an abnonormal heartrtbeat, whwhich can lelead to deata. itit can causese serious s sn rereactions, l liver problbl, and d low white e blood cell countnts that may r result in severe e infectionsns. tell youour doctor r right awy ifif you have e new or worsenining symptomoms, includining breathining proble, cocough, chestst pain, a change i in your heaeartbea, dizzinesess, yeyellowing ofof the skinn or eyeyes, dark ururine, tiredness,s, loss of a appeti, abdomen n pain, bleeeeding, brbruising, fefever, chilll, or othther symptomoms of an n infection,n, a a severe or r worsening g r, are e or plan toto become preg